BPG is committed to discovery and dissemination of knowledge
-
|
Homepage
|
-
|
Online Submission
|
- Number of total visits
-
30930115
- Number of visits today
- 133
- Number of downloads
-
13462554
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Kasala ER, Bodduluru LN, Barua CC. Chrysin and its emerging antineoplastic effects. Cancer Gene Ther 2016;23:43-43. [DOI: 10.1038/cgt.2015.65] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
2 |
Corey B, Chen H. Neuroendocrine Tumors of the Stomach. Surg Clin North Am. 2017;97:333-343. [PMID: 28325190 DOI: 10.1016/j.suc.2016.11.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
|
3 |
Guenter RE, Aweda T, Carmona Matos DM, Whitt J, Chang AW, Cheng EY, Liu XM, Chen H, Lapi SE, Jaskula-Sztul R. Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase Inhibitors. Cancers (Basel) 2019;11:E767. [PMID: 31163616 DOI: 10.3390/cancers11060767] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
|
4 |
Jain S, Pathak K, Vaidya A. Molecular therapy using siRNA: Recent trends and advances of multi target inhibition of cancer growth. International Journal of Biological Macromolecules 2018;116:880-92. [DOI: 10.1016/j.ijbiomac.2018.05.077] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
|
5 |
Talebi M, Talebi M, Farkhondeh T, Simal-Gandara J, Kopustinskiene DM, Bernatoniene J, Samarghandian S. Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin. Cancer Cell Int 2021;21:214. [PMID: 33858433 DOI: 10.1186/s12935-021-01906-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345